Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
AI is providing emotional support for employees – but is it a valuable tool or privacy threat? - 2US FDA grants market authorization to six on! PLUS nicotine pouch products
- 36 Home Cleaning Administrations to Keep Your Home Unblemished
- 4Novo Nordisk gears up for December Ozempic launch in India, sources say
- 5Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair.
- 10 Delectable Specialty Mixed drinks
- Damaged launch pad: How long before Russia can send astronauts to the ISS again?
- Pick Your Favored kind of soup
- Hungary's 'water guardian' farmers fight back against desertification
- It Looks Like a Tiny, Fluffy Dragon, But It's Really a Bird. Meet the Great Eared Nightjar
- EU waters down plans to end new petrol and diesel car sales by 2035
- 'We need everyone,' wounded reservist urges Knesset panel to advance haredi draft law
- Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- Guns N' Roses 2026 Tour: How to get tickets, presale times, prices and more
